Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04317586 · ClinicalTrials.gov registry record · NA
Trident II Revision Outcomes Study
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04317586 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 17 participants.
The verdict
NCT04317586, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to review the performance and success rate of an FDA cleared cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this happens in patients who have hip replacement with similar cementless acetabular shells.
Interventions
- DEVICE Trident II Tritanium Acetabular Shell for Revision
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-06-23 |
| Est. Completion | 2023-01-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04317586
The ClinicalTrials.gov registry entry for NCT04317586 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Orthopaedics, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Trident II Tritanium Acetabular Shell for Revision is the first listed.
NCT04317586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04317586 about?
NCT04317586 is a clinical study titled "Trident II Revision Outcomes Study". The purpose of this study is to review the performance and success rate of an FDA cleared cementless hip replacement part called the Trident II Tritanium Acetabular Shell. The study will specifically look at the need to revise the hip replacement after 5 years. This will be compared to how much this...
What is the current status of trial NCT04317586?
This trial is currently terminated. It is a NA study. The enrollment target is 17 participants. The study started on 2020-06-23. Estimated completion is 2023-01-27.
What interventions are being tested in trial NCT04317586?
The interventions under investigation include: Trident II Tritanium Acetabular Shell for Revision (DEVICE).
Who is sponsoring clinical trial NCT04317586?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.